Company
Therapeutic approach
News & Publications
Contact
Company
Therapeutic approach
News & Publications
Contact
Transformative pain therapeutics
Changing the course of pain for patients who need it most
Learn more
Scroll down
Who we are
Adynxx, located in San Francisco, is a clinical-stage biotechnology company developing a transformative technology platform addressing pain at its molecular roots. Adynxx’s unique approach is to transform pain management by approaching pain as a disease rather than a symptom.
Learn more
Therapeutic approach
 Provide safe, non-opioid, long-term pain reduction with a single administration
Clear mission
Developing transformative, first-in-class therapies to address significant unmet medical needs
Groundbreaking Science
A proprietary platform of non-opioid, disease-modifying oligonucleotide therapeutics
Tackling high unmet need
Focusing on patients who have the greatest need for innovative pain treatments
Learn more
News & Publications
Nov 15, 2018

					            		SAN FRANCISCO & MOUNTAIN VIEW, Calif.--November 15, 2018--Adynxx, Inc., a clinical-stage biotechnology company focused on pain and inflammation, and twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical company, today announced an agreement to develop an oral, non-hormonal drug therapy with the potential to address the underlying mechanisms of endometriosis and significantly improve upon the standard of care.					            	
Read more
Oct 12, 2018
Alliqua BioMedical Inc. and Adynxx, Inc. Announce Merger Agreement to Create NASDAQ-listed Clinical-Stage Pharmaceutical Company with a Focus on Pain and Inflammation
Apr 12, 2018
Adynxx Announces Results of the ADYX-004 Phase 2 Study of Brivoligide (AYX1) for the Treatment of Post-Surgical Pain
Oct 04, 2017
Adynxx Completes Enrollment in ADYX-004, a Phase 2 Study of Brivoligide (AYX1), Lead Compound for the Treatment of Post-Surgical Pain
View all news
Meet our team
Experienced management team with a proven track record of success dedicated to improving the life of patients
See all
Contact

        Your Name*
        

        Your Email*
        

        Subject
        

        Your Message
        
Adynxx (A – dȳ – nix), located in San Francisco, California, is a clinical stage
biotechnology company developing a transformative technology platform addressing pain at its molecular roots.
Office
100 Pine Street, Suite 500

San Francisco, CA 94111
Start a Conversation
+1.415.512.7740
info@adynxx.com
Site map
Homepage
Company
Therapeutic approach
News & Publications
Contact
Adynxx © 2018
Privacy policy
Terms of use
Financial Conflicts of Interest Policy